Latest news
Tectonic Therapeutic reports Q2 net loss $22.3M, cash $227.1M; TX45 enrollment complete - TradingViewTradingView · Thu, 06 Aug 2026 20:13:04 GMTAtavistik Bio Advances ATV-1601 With First Clinical Site in Harmony-HHT Trial - tipranks.comtipranks.com · Fri, 31 Jul 2026 09:27:24 GMTAtavistik Bio Partners with Cure HHT Clinical Trial Network to Advance Development of ATV-1601 for Hereditary Hemorrhagic Telangiectasia - Yahoo FinanceYahoo Finance · Thu, 30 Jul 2026 07:00:00 GMT